Endothelial nitric oxide synthase polymorphism in preeclampsia

Journal of the Society for Gynecologic Investigation

Volumn 10, Issue 3, 2003, Pages 154-157

  Häkli, Tanja ^a   Romppanen, Eeva Liisa ^a   Hiltunen, Mikko ^a   Helisalmi, Seppo ^a   Punnonen, Kari ^a   Heinonen, Seppo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

NOS; Polymorphism; Preeclampsia

Indexed keywords

NITRIC OXIDE SYNTHASE;

ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; ENDOTHELIUM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL;

ADULT; ASPARTIC ACID; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMIC ACID; HUMANS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 0037389280     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(03)00003-0     Document Type: Article

References (25)

1. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
2. Rapoport R.M., Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res. 52:1983;352-357.
3. Hogg N., Kalyanaraman B., Joseph J., Struck A., Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett. 334:1993;170-174.
4. Robinson L.J., Weremowicz S., Morton C.C., Michel T. Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. Genomics. 19:1994;350-357.
5. Hingorani A.D., Liang C.F., Fatibene J., et al. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 100:1999;1515-1520.
6. Miyamoto Y., Saito Y., Kajiyama N., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension. 32:1998;3-8.
7. Tesauro M., Thompson W.C., Rogliani P., Qi L., Chaudhary P.P., Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases Cleavage of proteins with aspartate vs glutamate at position 298 . Proc Natl Acad Sci U S A. 97:2000;2832-2835.
8. Sladek S.M., Magness R.R., Conrad K.P. Nitric oxide and pregnancy. Am J Physiol. 272:1997;R441-463.
9. Yallampalli C., Garfield R.E. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol. 169:1993;1316-1320.
10. Nobunaga T., Tokugawa Y., Hashimoto K., et al. Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest. 41:1996;189-193.
11. Smarason A.K., Allman K.G., Young D., Redman C.W. Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia. Br J Obstet Gynaecol. 104:1997;538-543.
12. Seligman S.P., Buyon J.P., Clancy R.M., Young B.K., Abramson S.B. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 171:1994;944-948.
13. Lopez-Jaramillo P., Narvaez M., Calle A., et al. Cyclic guanosine 3,5 monophosphate concentrations in pre-eclampsia Effects of hydralazine . Br J Obstet Gynaecol. 103:1996;33-38.
14. Napolitano M., Miceli F., Calce A., et al. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. J Clin Endocrinol Metab. 85:2000;2318-2323.
15. Savvidou M.D., Vallance P.J., Nicolaides K.H., Hingorani A.D. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension. 38:2001;1289-1293.
16. Bashford M.T., Hefler L.A., Vertrees T.W., Roa B.B., Gregg A.R. Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia. Am J Obstet Gynecol. 184:2001;1345-1350.
17. Yoshimura T., Yoshimura M., Tabata A., Yasue H., Okamura H. The missense Glu298Asp variant of the endothelial nitric oxide synthase gene is strongly associated with placental abruption. Hum Genet. 108:2001;181-183.
18. Yoshimura T., Yoshimura M., Tabata A., et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Investig. 7:2000;238-241.
19. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
20. Chen G., Wilson R., Wang S.H., Zheng H.Z., Walker J.J., McKillop J.H. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in preeclampsia. Clin Exp Immunol. 104:1996;154-159.
21. Ward K., Hata A., Jeunemaitre X., et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 4:1993;59-61.
22. Chen G., Wilson R., Boyd P., et al. Normal superoxide dismutase (SOD) gene in pregnancy-induced hypertension Is the decreased SOD activity a secondary phenomenon? Free Radic Res. 21:1994;59-66.
23. Dizon-Townson D.S., Nelson L.M., Easton K., Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol. 175:1996;902-905.
24. Sohda S., Arinami T., Hamada H., Yamada N., Hamaguchi H., Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet. 34:1997;525-526.
25. Peltonen L., Jalanko A., Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet. 8:1999;1913-1923.